Shalby Hospitals

205.98
+4.65
(2.31%)
Market Cap
2,224.79 Cr
EPS
7.78
PE Ratio
64.36
Dividend Yield
0.59 %
52 Week High
325.00
52 Week low
180.35
PB Ratio
2.16
Debt to Equity
0.29
Sector
Hospitals
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from1 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy100.00 %
100.00 %
Hold0.0 %
0.0 %
Sell0.0 %
0.0 %
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
990.70 96,309.12 90.76 5,584.10 18.77 1,058 -17.46 44.49
6,105.65 87,789.88 67.42 19,165.50 14.74 917 49.14 33.95
605.45 45,708.94 58.85 6,931.20 8.99 645 89.49 43.02
1,178.05 31,640.94 61.86 2,759.20 25.09 326 15.71 52.30
1,542.15 31,515.50 41.05 5,093.40 10.96 790 2.66 59.13
570.55 22,829.93 63.20 2,511.20 12.94 336 20.76 55.44
434.10 21,683.86 82.39 3,723.70 22.85 205 -69.22 51.21
1,260.75 12,803.13 53.06 1,334.00 10.76 218 10.06 40.48
1,524.05 9,992.59 51.25 1,095.50 21.32 177 20.14 53.65
496.95 6,927.62 125.69 1,929.10 12.97 41 129.41 46.49
Growth Rate
Revenue Growth
15.20 %
Net Income Growth
23.34 %
Cash Flow Change
-71.08 %
ROE
13.56 %
ROCE
9.78 %
EBITDA Margin (Avg.)
7.06 %

Quarterly Financial Results

Quarterly Financials
Jun 2017
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
91
119
122
115
116
133
128
123
119
41
118
134
147
195
184
165
167
206
207
207
208
240
243
221
249
289
275
281
Expenses
64
91
97
93
98
102
98
99
106
43
86
101
114
154
152
139
139
162
165
169
173
192
185
174
205
234
235
242
EBITDA
27
27
25
22
17
31
30
24
13
-3
32
33
33
41
32
27
28
44
42
38
35
48
58
47
44
55
40
39
Operating Profit %
29 %
21 %
19 %
17 %
13 %
22 %
22 %
18 %
2 %
-13 %
26 %
23 %
21 %
20 %
16 %
15 %
15 %
20 %
18 %
17 %
13 %
18 %
22 %
20 %
16 %
16 %
12 %
12 %
Depreciation
4
8
8
9
8
9
9
9
9
9
9
9
9
9
12
11
11
12
12
12
13
12
12
12
16
16
17
16
Interest
4
2
2
2
3
1
1
2
2
1
1
1
1
1
2
2
2
2
2
3
3
3
3
4
7
8
9
11
Profit Before Tax
19
18
15
12
7
21
20
14
2
-13
22
23
23
31
19
14
15
31
29
24
19
33
43
31
22
30
14
12
Tax
4
6
11
-2
4
-3
7
6
19
-4
-3
6
13
11
8
1
5
11
10
8
5
12
15
12
6
16
11
15
Net Profit
15
12
4
13
3
24
13
8
-17
-9
25
17
10
20
11
13
10
20
18
15
14
21
28
19
16
15
2
-3
EPS in ₹
1.63
1.11
0.33
1.24
0.30
2.19
1.20
0.75
-1.58
-0.81
2.27
1.56
0.91
1.87
0.99
1.20
0.94
1.87
1.71
1.42
1.29
1.94
2.57
1.78
1.49
1.37
0.22
-0.28

Balance Sheet

Balance Sheet
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
679
961
939
967
997
1,194
1,281
1,608
Fixed Assets
323
650
692
673
660
675
685
966
Current Assets
89
212
197
234
271
449
517
552
Capital Work in Progress
221
47
3
6
8
6
11
15
Investments
0
0
11
28
16
25
146
81
Other Assets
135
264
233
260
314
488
440
545
Total Liabilities
679
961
939
967
997
1,194
1,281
1,608
Current Liabilities
130
115
88
83
82
173
194
323
Non Current Liabilities
298
95
71
84
80
145
159
277
Total Equity
251
752
780
799
835
876
928
1,008
Reserve & Surplus
164
643
672
691
727
768
820
893
Share Capital
87
108
108
108
108
108
107
107

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
22
-19
3
0
-6
3
-2
49
-43
15
Investing Activities
-62
-98
-153
-236
1
-31
-51
-60
-61
146
Operating Activities
123
5
61
14
43
55
79
19
68
20
Financing Activities
-39
75
96
222
-51
-22
-30
91
-50
-151

Share Holding

% Holding
Mar 2021
May 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
79.45 %
74.07 %
74.07 %
74.02 %
74.02 %
74.02 %
74.04 %
74.04 %
74.12 %
74.12 %
74.12 %
74.12 %
74.12 %
74.24 %
74.25 %
74.25 %
74.27 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
4.11 %
4.62 %
4.88 %
5.35 %
5.37 %
4.65 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.06 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.06 %
0.09 %
0.14 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
11.68 %
11.97 %
11.14 %
11.16 %
12.03 %
11.86 %
11.91 %
11.95 %
11.06 %
11.13 %
11.28 %
11.35 %
10.66 %
10.40 %
9.97 %
10.09 %
10.78 %
Others
8.86 %
13.96 %
14.79 %
14.82 %
13.95 %
14.13 %
14.06 %
14.01 %
14.76 %
14.75 %
14.59 %
10.42 %
10.60 %
10.49 %
10.37 %
10.20 %
10.16 %
No of Share Holders
55,974
54,939
52,524
53,854
55,562
55,233
54,666
54,537
52,775
52,181
52,580
50,225
49,495
49,858
49,315
51,479
52,328

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.5 0.5 1 1 1.2 1.2 0.00
Dividend Yield (%) 0.00 0.00 0.00 1.08 0.5 0.85 0.77 0.5 0.6 0.00

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Credit Rating
9 days ago
Receipt Of Hand Transplant Approval
Feb 11, 2025, 19:55
Announcement under Regulation 30 (LODR)-Newspaper Publication
Feb 11, 2025, 15:09
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Feb 11, 2025, 12:48
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Feb 10, 2025, 11:20
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Feb 07, 2025, 18:58
Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015.
Feb 06, 2025, 19:32
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Feb 05, 2025, 17:52
Announcement under Regulation 30 (LODR)-Investor Presentation
Feb 04, 2025, 18:50
Announcement under Regulation 30 (LODR)-Newspaper Publication
Feb 04, 2025, 14:34
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Feb 04, 2025, 11:20
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Feb 03, 2025, 20:18
Integrated Filing (Financial)
Feb 03, 2025, 20:06
Announcement under Regulation 30 (LODR)-Change in Management
Feb 03, 2025, 19:53
Board Meeting Outcome for Outcome Of Board Meeting Held On 3Rd February 2025
Feb 03, 2025, 19:41
Unaudited Standalone And Consolidated Financial Results For Quarter Ended December 31 2024
Feb 03, 2025, 19:36
Update on board meeting
Jan 28, 2025, 15:59
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jan 28, 2025, 15:06
Board Meeting Intimation for Considering And Approving The Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31 2024 And Other Business Matters
Jan 28, 2025, 13:23
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jan 16, 2025, 17:52
Inauguration Of Shalby Tissue & Bone Bank At Krishna Shalby Hospital Ahmedabad
Jan 16, 2025, 14:05
Shalby Advanced Technologies (SAT) Inc. USA Received US FDA Approval For Its Product
Jan 15, 2025, 18:02
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 03, 2025, 16:50
Closure of Trading Window
Dec 27, 2024, 12:37
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Nov 28, 2024, 17:19
Disclosure Under Regulation 29(2) Of Securities Exchange Board Of India (Substantial Acquisition Of Shares And Takeover) Regulations, 2011
Nov 15, 2024, 16:22
Disclosure Under Regulation 7(2) Of Securities Exchange Board Of India (Prohibition Of Insider Trading) Regulations, 2015
Nov 15, 2024, 16:20
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Nov 06, 2024, 13:27
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Nov 05, 2024, 18:57
Announcement under Regulation 30 (LODR)-Newspaper Publication
Oct 31, 2024, 16:40
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Oct 30, 2024, 19:24
Announcement under Regulation 30 (LODR)-Investor Presentation
Oct 30, 2024, 14:10
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Oct 30, 2024, 12:51
Board Meeting Outcome for Outcome Of Board Meeting
Oct 30, 2024, 12:38
Unaudited Financials Results For Q2 & H1 FY25
Oct 30, 2024, 12:35
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Oct 25, 2024, 10:16
Announcement under Regulation 30 (LODR)-Change in Management
Oct 24, 2024, 16:47
Board Meeting Intimation for Approval Of Unaudited Standalone And Consolidated Financial Results For Quarter And Half Year Ended 30Th September 2024 And Other Business Matters
Oct 23, 2024, 12:45
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Oct 04, 2024, 12:44
Shalby Sanar International Hospitals Honored With AACI International Accreditation
Oct 03, 2024, 15:44
Shalby Multispecialty Hospital Honored With Prestigious 'Best Hospital Chain Of The Year (West) By Economic Times Healthcare Awards 2024
Sep 28, 2024, 12:15
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Sep 27, 2024, 16:24
Shareholder Meeting / Postal Ballot-Outcome of AGM
Sep 26, 2024, 18:31
Closure of Trading Window
Sep 25, 2024, 17:28
Receipt Of Bone Bank License
Sep 19, 2024, 19:17
Announcement under Regulation 30 (LODR)-Newspaper Publication
Sep 04, 2024, 13:34
Business Responsibility and Sustainability Reporting (BRSR)
Sep 03, 2024, 16:07
Reg. 34 (1) Annual Report.
Sep 03, 2024, 15:59
20Th Annual General Meeting Of The Members Of The Company To Be Held On September 26, 2024 At 4:00 P.M. IST
Sep 03, 2024, 15:23
Announcement under Regulation 30 (LODR)-Newspaper Publication
Aug 24, 2024, 16:57

Technical Indicators

RSI(14)
Neutral
51.05
ATR(14)
Less Volatile
9.84
STOCH(9,6)
Neutral
63.99
STOCH RSI(14)
Overbought
81.29
MACD(12,26)
Bullish
1.69
ADX(14)
Weak Trend
16.26
UO(9)
Bearish
51.04
ROC(12)
Uptrend And Accelerating
0.97
WillR(14)
Neutral
-28.11